Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteins

Mafalda Cacciottolo(University of Southern California), Minghao Sun(Capricor Therapeutics (United States))
bioRxiv (Cold Spring Harbor Laboratory)
January 11, 2023
Cited by 2


Related Papers